76 filings
8-K
SRRK
Scholar Rock Holding Corp
3 Jun 24
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
4:25pm
8-K
SRRK
Scholar Rock Holding Corp
22 May 24
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
8:30am
8-K
SRRK
Scholar Rock Holding Corp
14 May 24
Entry into a Material Definitive Agreement
7:15am
8-K
SRRK
Scholar Rock Holding Corp
7 May 24
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
7:20am
8-K
SRRK
Scholar Rock Holding Corp
19 Mar 24
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
7:07am
8-K
ep151ql
15 Feb 24
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
8:57am
8-K
2bbsu ohhtbwpdl38w
8 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
9dxc 02x5dhk
7 Nov 23
Results of Operations and Financial Condition
7:15am
8-K
lk4llhi
12 Oct 23
Scholar Rock Announces Proposed Public Offering of Common Stock
5:02pm
8-K
1n1p9
11 Oct 23
Scholar Rock TO ADVANCE ANTIMYOSTATIN PROGRAM to develop novel therapies for CARDIOMETABOLIC DISORDERS
4:48pm
8-K
6mv7qiks
9 Aug 23
Results of Operations and Financial Condition
4:16pm
8-K
uus7tvj0pfg0c6anh1zp
30 Jun 23
Regulation FD Disclosure
11:04am
8-K
5b10 xrfattm
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
8imu9n wp
9 May 23
Results of Operations and Financial Condition
7:30am
8-K
io327
10 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
nsn4 duza
10 Mar 23
Regulation FD Disclosure
6:39pm
8-K
9dxxe udvtsn
7 Mar 23
Results of Operations and Financial Condition
7:50am
8-K
i62n0gcud fp2
9 Jan 23
Regulation FD Disclosure
8:01am
8-K
xdrwlu8 vq
14 Nov 22
Results of Operations and Financial Condition
8:00am
8-K
uio06 1ais73bx74h3hv
9 Nov 22
Departure of Directors or Certain Officers
8:00am